-
The number of infants born with HIV-infection in the United States reached its peak in 1991 with about 1650 HIV-infected infants, at which point the implementation of prevention guidelines resulted in a rapid reduction in neonatal infection.
-
A retrospective analysis was conducted of all blood cultures collected on full-term (>=37 weeks) previously healthy infants presenting for care from 1 week to 3 months of age in a large California healthcare system over 5 years (2005-2009).
-
In a recent discussion of a clinical case in the New England Journal of Medicine, the authors correctly indicate itraconazole is recommended for all but the most severe cases of disseminated histoplasmosis (when amphotericin B is used).
-
-
This study was a secondary analysis of data from an earlier randomized clinical trial comparing one antibiotic vs two (meropenem alone or meropenem plus ciprofloxacin) as early empiric therapy for ventilator-associated pneumonia (VAP).
-
Looking for a quality improvement (QI) project targeting catheter-associated urinary tract infections (CAUTIs)? Here's one that produced dramatic results, including a 68% decline in the CAUTI rate and a 20% reduction in the use of indwelling urinary catheters.
-
In light of recurrent outbreaks linked to misuse of single-dose medication vials, the Centers for Disease Control and Prevention is emphasizing that medications labeled as "single dose" or "single use" are to be used for only one patient.
-
In what is getting to be a familiar, tragic refrain, the improper use of single-dose vials recently resulted in patients at pain clinics in Arizona and Delaware acquiring serious bacterial infections that were "completely preventable," the Centers for Disease Control and Prevention reports.
-
The Centers for Disease Control and Prevention is trying to overcome some stubborn myths and misperceptions about single-dose vials including the following, which the agency refuted with the current facts.
-
A Centers for Medicare & Medicaid Services draft infection control survey expected to be finalized for use in hospitals next year could lead to increased support and appreciation for the challenges faced by central services departments, says Rose Seavey, RN, BS, MBA, CNOR, CRCST, CSPDT, President/CEO of Seavey Healthcare Consulting, Inc., in Arvada, CO.
